Hyundai will field Dani Sordo in its third WRC car in next month's Safari Rally Kenya. But a decision on who will complete the squad's driver line-up after Craig Breen's death is yet to be made.
The team’s plans for its third car for the remainder of the WRC season are yet to be determined following the tragic passing ofVeteran Sordo had been announced to pilot the third i20 N for Portugal two weeks ago, where he finished second, before Breen’s death in a Croatia testing accident in April.
The South Korean marque has however confirmed that Sordo won’t contest all of the remaining rallies on the calendar, but has selected the 40-year-old for next week’s round in Sardinia , with the following round in Kenya now added to his programme.piloted the third car in one of his eight outings, before the team elected to part ways with the driver before the end of the season.
Hyundai team principal Cyril Abiteboul told Motorsport.com in Portugal that the process to complete its driver line-up is ongoing, with the
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Superbike riders rally behind Lee Johnston with Donington Park gestureFermanagh rider Lee Johnston suffered serious injuries following a crash at the North West 200
Read more »
Thousands mass for pro-EU rally in Moldovan capital, amid tensions with RussiaMoldovan President Maia Sandu is vying for EU member status, amid fears of a Russian-backed coup.
Read more »
The Japan rally\n\t\t\tLet our global subject matter experts broaden your perspective with timely insights and opinions you\n\t\t\tcan’t find anywhere else.\n\t\t
Read more »
Welsh independence march in SwanseaSwansea's rally comes after an estimated 10,000 marched in Cardiff and 8,000 in Wrexham last year.
Read more »
New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants - BMC MedicineAs new, efficacious respiratory syncytial virus (RSV) immunization products reach the market, affordable pricing as well as improved estimation of disease burden and the full potential and cost effectiveness of RSV prevention in the hardest hit geographies in low- and middle-income countries are critical to inform country adoption and enable maximum impact against infant disease and mortality globally. The data reported in the special issue underscore the enormous burden, and associated cost, of RSV disease in young infants in several LMICs, including Kenya and South Africa, as well as the potential for RSV maternal vaccines or long-acting monoclonal antibodies, to be cost-effective and possibly even cost-saving.
Read more »
23 health conditions that make you eligible for £300 a month supportThe support aims to help with living costs if you’re unable to work
Read more »